Posted by Clinical Lab Products | Apr 9, 2009 | Infectious Diseases, Molecular Diagnostics |
There is still plenty of unmet need in US laboratories for new molecular testing equipment, according to a new Kalorama Information market research report based on a 2008 survey of 1000 interviews with laboratories.
Read MorePosted by Clinical Lab Products | Apr 9, 2009 | Miscellaneous |
Beckman Coulter Inc has expanded its drugs of abuse test menu to include a DRI* Oxycodone Enzyme Immunoassay (OXYX). The assay is for the qualitative and semi-quantitative determination of oxycodone and its metabolite, oxymorphone, in human urine.
Read MorePosted by Clinical Lab Products | Apr 7, 2009 | Miscellaneous |
Beckman Coulter Inc has expanded its Renal menu with the addition of Gentian* Cystatin C Immunoassay (CYSX), an assay for the quantitative determination of cystatin C in human serum and plasma.
Read MorePosted by Clinical Lab Products | Mar 25, 2009 | Infectious Diseases, Sexually Transmitted Diseases |
BD Diagnostics, a segment of BD (Becton, Dickinson, and Company), announces that it has received 510(k) clearance from the FDA for the BD ProbeTec Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay.
Read MorePosted by Clinical Lab Products | Mar 9, 2009 | Miscellaneous |
B-R-A-H-M-S Aktiengesellschaft announces that it has submitted 510(k) file to the FDA to market its patented B-R-A-H-M-S MR-proANP Kryptor Test.
Read More